Prognostic value of IDH1 mutations identified with PCR-RFLP assay in glioblastoma patients.

Bujko, Mateusz; Kober, Paulina; Matyja, Ewa; Nauman, Pawel; Dyttus-Cebulok, Katarzyna; Czeremszynska, Beata; Bonicki, Wieslaw; Siedlecki, Janusz A

Bujko, Mateusz; Kober, Paulina; Matyja, Ewa; Nauman, Pawel; Dyttus-Cebulok, Katarzyna; Czeremszynska, Beata; Bonicki, Wieslaw; Siedlecki, Janusz A.

Affiliation

Bujko M; Department of Molecular Biology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. mbujko@coi.waw.pl

Mol Diagn Ther ; 14(3): 163-9, 2010 Jun 01.

Article in En | MEDLINE | ID: mdl-20560678

Subject(s)

Biological Assay/methods; Glioblastoma/enzymology; Glioblastoma/genetics; Isocitrate Dehydrogenase/genetics; Mutation/genetics; Polymerase Chain Reaction/methods; Polymorphism, Restriction Fragment Length/genetics; Adult; Aged; Disease-Free Survival; Female; Glioblastoma/diagnosis; Humans; Male; Middle Aged; Prognosis; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Assay / Polymorphism, Restriction Fragment Length / Polymerase Chain Reaction / Glioblastoma / Isocitrate Dehydrogenase / Mutation Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Mol Diagn Ther Journal subject: BIOLOGIA MOLECULAR / FARMACOLOGIA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Year: 2010 Type: Article Affiliation country: Poland

Fulltext

XML

PubMed Links

Search on Google